CME and ICE dey push CFTC make dem check Hyperliquid after HYPE drop
CME Group and ICE don dey beg US regulators, including CFTC and Congress, make dem check Hyperliquid over alleged market manipulation and risk say dem fit waka comot sanctions because of dia anonymous, 24/7 perpetual futures trading. After Bloomberg report, Hyperliquid HYPE token drop about 6%, fall from above $45 to below $43.
The exchanges talk say Hyperliquid permissionless setup fit allow coordinated insider activity and fit disturb global commodity benchmarks, especially oil-linked markets. Hyperliquid through im Policy Center wey CEO Jake Chervinsky lead, dey reject am, say im on-chain public trading records dey improve transparency and make regulators fit see wetin dey happen. Dem still talk say 24/7 trading na efficiency upgrade, no be market disruption.
Hyperliquid don expand past on-chain perps into synthetic stocks and commodities, so e dey compete more directly with CME and ICE. The policy team dey separately engage CFTC to ask for tailored regulatory framework for on-chain derivatives and possible legal path for US retail to join. No formal regulatory action don announce, but this pressure campaign don add uncertainty for Hyperliquid and traders wey hold HYPE.
Bearish
Di news fit likely be short-term bearish for HYPE because e raise regulatory uncertainty around Hyperliquid’s permissionless, anonymous 24/7 perpetual futures model. That uncertainty fit pressure liquidity and risk appetite, wey match the immediate ~6% token drop after the Bloomberg-triggered lobbying push. Even though Hyperliquid talk say their on-chain transparency reduce manipulation and sanctions-evasion risk, the lack of announced resolution and the chance of future CFTC scrutiny fit make traders cautious.
For long-term, the outcome depend on whether CFTC go adopt tailored framework for on-chain derivatives. If clear regulatory pathway show, the bearish effect fit fade. For now, the main market reaction na concern about potential enforcement and allegations say Hyperliquid fit distort benchmarks.